Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_assertion type Assertion NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_head.
- NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_provenance.
- NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_assertion evidence source_evidence_literature NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_provenance.
- NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_assertion SIO_000772 15262134 NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_provenance.
- NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_assertion wasDerivedFrom befree-20150227 NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_provenance.
- NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_assertion wasGeneratedBy ECO_0000203 NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_provenance.